Xylazine — Medical and Public Health Imperatives
New England Journal of Medicine · 15.06.2023 · 388 (24) · 2209-2212
DOI: 10.1056/nejmp2303120 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, erschienen am 15.06.2023. Verfasst von Rahul Gupta und 2 weiteren Autor:innen. Beteiligte Einrichtung: From the White House Office of National Drug Control Policy, Washington, DC (R.G., D.R.H., M.A.A.); and the Department of Anesthesiology and Critical…. Hauptthemen laut MEDLINE: Xylazine, Public Health. Die Arbeit wurde bisher 156-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the White House Office of National Drug Control Policy, Washington, DC (R.G., D.R.H., M.A.A.); and the Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia (M.A.A.).
Zitieren
APA
Gupta, R., Holtgrave, D. R., & Ashburn, M. A. (2023). Xylazine — Medical and Public Health Imperatives. New England Journal of Medicine, 388(24), 2209-2212. https://doi.org/10.1056/nejmp2303120
Vancouver
Gupta R, Holtgrave DR, Ashburn MA. Xylazine — Medical and Public Health Imperatives. New England Journal of Medicine. 2023;388(24):2209-2212. doi:10.1056/nejmp2303120
BibTeX
@article{Gupta2023,
author = {Gupta, Rahul and Holtgrave, David R and Ashburn, Michael A},
title = {Xylazine — Medical and Public Health Imperatives},
journal = {New England Journal of Medicine},
year = {2023},
volume = {388},
number = {24},
pages = {2209--2212},
doi = {10.1056/nejmp2303120}
}
EUVIMED